AH
AHCO icon

Andreas Halvorsen’s AdaptHealth AHCO Stock Holding History

Andreas Halvorsen’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,949,783
Closed -$96.6M – 92
2021
Q4 		$96.6M Sell
3,949,783
-124,246
-3% -$2.92M 0.28% 73
2021
Q3 		$94.9M Buy
4,074,029
+977,601
+32% +$23.6M 0.26% 71
2021
Q2 		$84.9M Buy
+3,096,428
New +$88.3M 0.26% 66

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Andreas Halvorsen's AHCO Position: Q1 2022 in Review

Andreas Halvorsen sold out of AdaptHealth (AHCO) in Q1 2022, closing a stake of 3,949,783 shares — an estimated $96.6M sold.

Andreas Halvorsen first reported a position in AHCO in Q2 2021 and held it in 3 quarters. The position peaked at $96.6M in Q4 2021. 154 funds tracked by Wall St. Rank hold AHCO as of Q1 2022.

  • Andreas Halvorsen reported no remaining AdaptHealth position as of Q1 2022 after selling out during the quarter.
  • Andreas Halvorsen sold 3,949,783 AdaptHealth shares in Q1 2022, an estimated $96.6M.
  • Andreas Halvorsen first reported a position in AdaptHealth in Q2 2021 and held it in 3 quarters.
  • Andreas Halvorsen's AdaptHealth position peaked at $96.6M in Q4 2021.
  • 154 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2022.

Based on Viking Global Investors's 13F filing for Q1 2022, filed 16 May 2022.